tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeet Mukherjee, 31 are a BUY (96.88%), 1 are a HOLD (3.13%).
Analyst Jeet Mukherjee, currently employed at BTIG, carries an average stock price target met ratio of 9.52% that have a potential upside of 21.46% achieved within 41 days.
Jeet Mukherjee’s has documented 61 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VSTM, Verastem at 02-Jul-2026.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 9/9/2025. The price target of $87 was fulfilled within 23 days with a profit of $42.07 (93.63%) receiving and performance score of 40.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2024
$18
$10 (125.00%)
$15
1 months 5 days ago
(03-Jun-2026)
0/4 (0%)
$10.3 (133.77%)
Buy Since 05-Mar-2026
$24
$16 (200.00%)
$21
2 months 4 days ago
(04-May-2026)
7/18 (38.89%)
$13.22 (122.63%)
93
Buy Since 02-May-2025
$16
$8 (100.00%)
$14
3 months 19 days ago
(19-Mar-2026)
0/3 (0%)
$4.83 (43.24%)
Hold Since 18-Sep-2025
$11
$3 (37.50%)
$9
4 months 13 days ago
(25-Feb-2026)
11/16 (68.75%)
$-2.3 (-17.29%)
114
Buy Since 22-Oct-2018
$20
$12 (150.00%)
4 months 13 days ago
(25-Feb-2026)
9/13 (69.23%)
$6.7 (50.38%)
180
Which stock is Jeet Mukherjee is most bullish on?
Which stock is Jeet Mukherjee is most reserved on?
What Year was the first public recommendation made by Jeet Mukherjee?
